shogaol and Sepsis

shogaol has been researched along with Sepsis* in 1 studies

Other Studies

1 other study(ies) available for shogaol and Sepsis

ArticleYear
6-Shogaol Mitigates Sepsis-Associated Hepatic Injury through Transcriptional Regulation.
    Nutrients, 2021, Sep-28, Volume: 13, Issue:10

    Sepsis-associated liver dysfunction presents a significant public health problem. 6-Shogaol is the key bioactive component in dry ginger, which has antioxidant and anti-inflammation capacity. The present study aims to investigate the preventive effect of 6-shogaol on sepsis-induced liver injury. 6-Shogaol was administered to mice for 7 consecutive days before being intraperitoneally injected with lipopolysaccharide (LPS). After 24 h, mice were sacrificed, and biochemical and transcriptomic analyses were performed. Our results demonstrated that 6-shogaol prevented LPS-induced impairment in antioxidant enzymes and elevation in malondialdehyde level in the liver. The hepatic inflammatory response was significantly suppressed by 6-shogaol through suppressing the MAPK/NFκB pathway. RNA-sequencing data analysis revealed that 41 overlapped genes between the LPS vs. control group and 6-shogaol vs. LPS group were identified, among which 36 genes were upregulated, and 5 genes were downregulated for the LPS vs. control group. These overlapped genes are enriched in inflammation-related pathways, e.g., TNF and NFκB. The mRNA expression of the overlapped genes was also verified in the LPS-induced BRL-3A cell model. In summary, 6-shogaol shows great potential as a natural chemopreventive agent to treat sepsis-associated hepatic disorders.

    Topics: Animals; Biomarkers; Catechols; Computational Biology; Disease Management; Disease Models, Animal; Disease Susceptibility; Gene Expression Profiling; Gene Expression Regulation; Liver Diseases; Liver Function Tests; Mice; NF-kappa B; Oxidative Stress; Sepsis; Signal Transduction; Transcription, Genetic; Transcriptome

2021